Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative Oncology for Biochemical Recurrence of Epithelial Ovarian Cancer.

Current oncology reports·2026
Same author

A National Multi-Disciplinary Integrative Oncology Training Program in Israel: Trainee Perspectives.

Journal of pain and symptom management·2025
Same author

Feasibility, Usability, and Satisfaction of a Decision Support Tool to Prevent Community-Acquired Pressure Injuries for Use in the Spinal Cord Injury Clinic.

Medical care·2025
Same author

Editorial: Diet, Nutrition, Supplements, and Integrative Oncology in Cancer Care.

Nutrients·2025
Same author

Integrative Oncology Approaches Beneficial to Patients in Radiation Therapy.

Current oncology reports·2025
Same author

The Role of Integrative Oncology in Patients Affected by Triple Negative Breast Cancer.

Current oncology reports·2025
Same journal

Music for patients with hematological malignancies undergoing bone marrow biopsy: a randomized controlled study of anxiety, perceived pain, and patient satisfaction.

Journal of the Society for Integrative Oncology·2014
Same journal

Patient-doctor communication: use of complementary and alternative medicine by adult patients with cancer.

Journal of the Society for Integrative Oncology·2010
Same journal

Yoga improves quality of life and benefit finding in women undergoing radiotherapy for breast cancer.

Journal of the Society for Integrative Oncology·2010
Same journal

Phase II Randomized Trial of Acupuncture-Like Transcutaneous Electrical Nerve Stimulation to Prevent Radiation-Induced Xerostomia in Head and Neck Cancer Patients.

Journal of the Society for Integrative Oncology·2010
Same journal

Phytoestrogens: science, evidence, and advice for breast cancer patients.

Journal of the Society for Integrative Oncology·2010
Same journal

Team science of nursing, engineering, statistics, and practitioner in the development of a robotic reflexology device.

Journal of the Society for Integrative Oncology·2010
See all related articles

Related Experiment Videos

Managing radiation therapy side effects with complementary medicine.

Jerah Thomas, Curtiss Beinhorn, Dena Norton

    Journal of the Society for Integrative Oncology
    |April 15, 2010
    PubMed
    Summary
    This summary is machine-generated.

    Complementary and alternative medicine (CAM) use is common in cancer patients. This review explores beneficial CAM therapies to reduce radiation therapy symptom burden, incorporating practitioner insights.

    Related Experiment Videos

    Area of Science:

    • Integrative oncology
    • Radiation oncology
    • Complementary and alternative medicine (CAM)

    Background:

    • Over one-third of Americans utilize complementary and alternative medicine (CAM).
    • CAM use may be even more prevalent among cancer patients.
    • Integrating CAM into cancer care is increasingly accepted.

    Purpose of the Study:

    • To review potential CAM therapies effective in alleviating radiation therapy-related symptoms.
    • To provide clinical observations from CAM practitioners at a comprehensive cancer center.

    Main Methods:

    • Literature review of CAM therapies for symptom management in radiation therapy patients.
    • Inclusion of clinical insights from experienced CAM practitioners.

    Main Results:

    • Identified CAM therapies that may effectively reduce symptom burden associated with radiation therapy.
    • Highlighted the practical application and observations of CAM in a clinical oncology setting.

    Conclusions:

    • CAM therapies show promise in mitigating symptoms experienced by radiation therapy patients.
    • Further research is needed to validate beneficial CAM interventions in this population.